Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.24.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Product sales $ 25 $ 4
Operating cost and expense    
Plant operations 6,282 3,959
Research and development cost 1,741 1,813
Impairment of equipment 4,851 579
Gain on disposal of property, plant and equipment (23) (596)
General and administrative expense 11,638 9,815
Total operating expense 24,489 15,570
Loss from operations (24,464) (15,566)
Other income and expense    
Interest expense (621) (125)
Interest and other income 1,147 262
Total other income (expense), net 526 137
Loss before income tax expense (23,938) (15,429)
Income tax expense (2) (2)
Net loss $ (23,938) $ (15,431)
Weighted average shares outstanding, basic and diluted (in shares) 93,931,948 75,811,034
Basic and diluted net loss per share (in dollars per share) $ (0.25) $ (0.2)